The DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology
Open accessAbstract
The study of botulinum neurotoxins (BoNT) is rapidly progressing in many aspects. Novel BoNTs are being discovered owing to next generation sequencing, but their biologic and pharmacological properties remain largely unknown. The molecular structure of the large protein complexes that the toxin forms with accessory proteins, which are included in some BoNT type A1 and B1 pharmacological preparations, have been determined. By far the largest effort has been dedicated to the testing and validation of BoNTs as therapeutic agents in an ever increasing number of applications, including pain therapy. BoNT type A1 has been also exploited in a variety of cosmetic treatments, alone or in combination with other agents, and this specific market has reached the size of the one dedicated to the treatment of medical syndromes. The pharmacological properties and mode of action of BoNTs have shed light on general principles of neuronal transport and protein-protein interactions and are stimulating basic science studies. Moreover, the wide array of BoNTs discovered and to be discovered and the production of recombinant BoNTs endowed with specific properties suggest novel uses in therapeutics with increasing disease/symptom specifity. These recent developments are reviewed here to provide an updated picture of the biologic mechanism of action of BoNTs, of their increasing use in pharmacology and in cosmetics, and of their toxicology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Lipid rafts and signal transduction
Simons, K., & Toomre, D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036052 · Cited by 5,371
SNAREs — engines for membrane fusion
Jahn, R., & Scheller, R. H. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2002 · Cited by 2,635
Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins
Miesenböck, G., De Angelis, D. A., & Rothman, J. E. (1998) · Nature · doi:10.1038/28190 · Cited by 2,563
Physiological functions of thioredoxin and thioredoxin reductase
Arnér, E. S. J., & Holmgren, A. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01701.x · Cited by 2,525
Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 Å resolution
Sutton, R. B., Fasshauer, D., Jahn, R., & Brunger, A. T. (1998) · Nature · doi:10.1038/26412 · Cited by 2,417 · cited 1×
“3), preventing the formation of a stable SNARE complex and consequently of exocytosis (Hayashi et al., 1994; Sutton et al., 1998).”
BackgroundMolecular anatomy of a trafficking organelle
Takamori, S., Holt, M., Stenius, K., Lemke, E. A., Grønborg, M., Riedel, D., Urlaub, H., Schenck, S., Brügger, B., Ringler, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.10.030 · Cited by 2,373
Botulinum Toxin as a Biological Weapon: Medical and Public Health Management
Arnon, S. S., Schechter, R., Inglesby, T. V., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., Fine, A. D., Hauer, J., Layton, M., et al. (2001) · JAMA · doi:10.1001/jama.285.8.1059 · Cited by 1,814
Schiavo, G. G., Benfenati, F., Poulain, B., Rossetto, O., de Laureto, P. P., DasGupta, B. R., & Montecucco, C. (1992) · Nature · doi:10.1038/359832a0 · Cited by 1,805
Self-citationVertebrate protein glycosylation: diversity, synthesis and function
Moremen, K. W., Tiemeyer, M., & Nairn, A. V. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3383 · Cited by 1,677
DEVELOPMENT OF THE VERTEBRATE NEUROMUSCULAR JUNCTION
Sanes, J. R., & Lichtman, J. W. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.389 · Cited by 1,532
The neural control of micturition
Fowler, C. J., Griffiths, D., & de Groat, W. C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2401 · Cited by 1,485
Syntaxin: A Synaptic Protein Implicated in Docking of Synaptic Vesicles at Presynaptic Active Zones
Bennett, M. K., Calakos, N., & Scheller, R. H. (1992) · Science · doi:10.1126/science.1321498 · Cited by 1,263
Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25
Blasi, J., Chapman, E. R., Link, E., Binz, T., Yamasaki, S., Camilli, P. D., Südhof, T. C., Niemann, H., & Jahn, R. (1993) · Nature · doi:10.1038/365160a0 · Cited by 1,220
Rush, A. J. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.11.1905 · Cited by 870
SCHURCH, B., STÖHRER, M., KRAMER, G., SCHMID, D. M., GAUL, G., & HAURI, D. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67283-7 · Cited by 822
Oyler, G. A., Higgins, G. A., Hart, R. A., Battenberg, E., Billingsley, M., Bloom, F. E., & Wilson, M. C. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.6.3039 · Cited by 807
Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly.
Hayashi, T., McMahon, H., Yamasaki, S., Binz, T., Hata, Y., Südhof, T. C., & Niemann, H. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06834.x · Cited by 797
SV2 Is the Protein Receptor for Botulinum Neurotoxin A
Dong, M., Yeh, F., Tepp, W. H., Dean, C., Johnson, E. A., Janz, R., & Chapman, E. R. (2006) · Science · doi:10.1126/science.1123654 · Cited by 770
Crystal structure of botulinum neurotoxin type A and implications for toxicity
Lacy, D. B., Tepp, W., Cohen, A. C., DasGupta, B. R., & Stevens, R. C. (1998) · Nature Structural Biology · doi:10.1038/2338 · Cited by 766
Pietrobon, D., & Moskowitz, M. A. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183717 · Cited by 680
Evidence for a molten globule state as a general intermediate in protein folding
Ptitsyn, O. B., Pain, R. H., Semisotnov, G. V., Zerovnik, E., & Razgulyaev, O. I. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80143-7 · Cited by 678
Hanschmann, E.-M., Godoy, J. R., Berndt, C., Hudemann, C., & Lillig, C. H. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4599 · Cited by 677
de Paiva, A., Meunier, F. A., Molgó, J., Aoki, K. R., & Dolly, J. O. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3200 · Cited by 673
Botulinum neurotoxins: genetic, structural and mechanistic insights
Rossetto, O., Pirazzini, M., & Montecucco, C. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3295 · Cited by 634
Self-citationBacterial toxins: a table of lethal amounts
Gill, D. M. (1982) · Microbiological Reviews · doi:10.1128/mr.46.1.86-94.1982 · Cited by 629
Simpson, D. M., Blitzer, A., Brashear, A., Comella, C., Dubinsky, R., Hallett, M., Jankovic, J., Karp, B., Ludlow, C. L., Miyasaki, J. M., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000311389.26145.95 · Cited by 618
Treatment of Glabellar Frown Lines with C. Botulinum‐A Exotoxin
CARRUTHERS, J. D. A., & CARRUTHERS, J. A. (1992) · The Journal of Dermatologic Surgery and Oncology · doi:10.1111/j.1524-4725.1992.tb03295.x · Cited by 612
Single-Particle Cryo-EM at Crystallographic Resolution
Cheng, Y. (2015) · Cell · doi:10.1016/j.cell.2015.03.049 · Cited by 581
Origin of pain in migraine: evidence for peripheral sensitisation
Olesen, J., Burstein, R., Ashina, M., & Tfelt-Hansen, P. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70090-0 · Cited by 564
Intrasphincteric Botulinum Toxin for the Treatment of Achalasia
Pasricha, P. J., Ravich, W. J., Hendrix, T. R., Sostre, S., Jones, B., & Kalloo, A. N. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321203 · Cited by 556
Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin.
Blasi, J., Chapman, E. R., Yamasaki, S., Binz, T., Niemann, H., & Jahn, R. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06171.x · Cited by 545
Thioredoxins and Glutaredoxins: Unifying Elements in Redox Biology
Meyer, Y., Buchanan, B. B., Vignols, F., & Reichheld, J.-P. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102108-134201 · Cited by 488
The mechanisms and functions of spontaneous neurotransmitter release
Kavalali, E. T. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3875 · Cited by 486
Structure and function of tetanus and botulinum neurotoxins
Montecucco, C., & Schiavo, G. (1995) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500003292 · Cited by 472
Self-citationRab5 and Rab7 Control Endocytic Sorting along the Axonal Retrograde Transport Pathway
Deinhardt, K., Salinas, S., Verastegui, C., Watson, R., Worth, D., Hanrahan, S., Bucci, C., & Schiavo, G. (2006) · Neuron · doi:10.1016/j.neuron.2006.08.018 · Cited by 467
Saheki, Y., & De Camilli, P. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005645 · Cited by 457
Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B.
Swaminathan, S., & Eswaramoorthy, S. (2000) · Nature Structural Biology · doi:10.1038/78005 · Cited by 452
Long-Distance Retrograde Effects of Botulinum Neurotoxin A
Antonucci, F., Rossi, C., Gianfranceschi, L., Rossetto, O., & Caleo, M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0375-08.2008 · Cited by 450
Self-citationPandolfino, J. E., & Gawron, A. J. (2015) · JAMA · doi:10.1001/jama.2015.2996 · Cited by 449
Botulinum neurotoxins serotypes A and E cleave SNAP‐25 at distinct COOH‐terminal peptide bonds
Schiavo, G., Santucci, A., Dasgupta, B. R., Mehta, P. P., Jontes, J., Benfenati, F., Wilson, M. C., & Montecucco, C. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80448-4 · Cited by 438
Self-citationSafety and efficacy of NeuroBloc (botulinum toxin type B) in type A–resistant cervical dystonia
Brin, M. F., Lew, M. F., Adler, C. H., Comella, C. L., Factor, S. A., Jankovic, J., O’Brien, C., Murray, J. J., Wallace, J. D., Willmer–Hulme, A., et al. (1999) · Neurology · doi:10.1212/wnl.53.7.1431 · Cited by 437
Treatment of Glabellar Frown Lines with C. Botulinum-A Exotoxin
Ramesh, S. (2022) · Foundational Papers in Oculoplastics · doi:10.1007/978-3-030-92794-3_9 · Cited by 434
Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E.
Schiavo, G., Rossetto, O., Catsicas, S., Polverino de Laureto, P., DasGupta, B. R., Benfenati, F., & Montecucco, C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80452-9 · Cited by 426
Self-citationA 'molten-globule' membrane-insertion intermediate of the pore-forming domain of colicin A
van der Goot, F. G., González-Mañas, J. M., Lakey, J. H., & Pattus, F. (1991) · Nature · doi:10.1038/354408a0 · Cited by 418
Functions and mechanisms of retrograde neurotrophin signalling
Zweifel, L. S., Kuruvilla, R., & Ginty, D. D. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1727 · Cited by 413
Botulinum Neurotoxin: A Marvel of Protein Design
Montal, M. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.051908.125345 · Cited by 411
How do tetanus and botulinum toxins bind to neuronal membranes?
Montecucco, C. (1986) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(86)90282-3 · Cited by 400
Self-citationBacterial toxins: cellular mechanisms of action
Middlebrook, J. L., & Dorland, R. B. (1984) · Microbiological Reviews · doi:10.1128/mmbr.48.3.199-221.1984 · Cited by 357
Gangliosides as components of lipid membrane domains
Sonnino, S., Mauri, L., Chigorno, V., & Prinetti, A. (2007) · Glycobiology · doi:10.1093/glycob/cwl052 · Cited by 346
Foran, P. G., Mohammed, N., Lisk, G. O., Nagwaney, S., Lawrence, G. W., Johnson, E., Smith, L., Aoki, K. R., & Dolly, J. O. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209821200 · Cited by 340
Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin
Schiavo, G., Shone, C. C., Rossetto, O., Alexander, F. C., & Montecucco, C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50230-7 · Cited by 337
Self-citationSubstrate recognition strategy for botulinum neurotoxin serotype A
Breidenbach, M. A., & Brunger, A. T. (2004) · Nature · doi:10.1038/nature03123 · Cited by 330
Translocation of botulinum neurotoxin light chain protease through the heavy chain channel
Koriazova, L. K., & Montal, M. (2003) · Nature Structural Biology · doi:10.1038/nsb879 · Cited by 327
Elferink, L. A., Trimble, W. S., & Scheller, R. H. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60426-0 · Cited by 322
Bacterial toxins: a table of lethal amounts.
Dm, G. (1982) · Microbiological Reviews · doi:10.1128/mmbr.46.1.86-94.1982 · Cited by 322
The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves
Mahrhold, S., Rummel, A., Bigalke, H., Davletov, B., & Binz, T. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.02.074 · Cited by 315
Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization
Dolly, J. O., Black, J., Williams, R. S., & Melling, J. (1984) · Nature · doi:10.1038/307457a0 · Cited by 314
Nishiki, T., Kamata, Y., Nemoto, Y., Omori, A., Ito, T., Takahashi, M., & Kozaki, S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34087-5 · Cited by 305
A Pilot Study on the Use of Botulinum Toxin in Spasmodic Torticollis
Tsui, J. K., Eisen, A., Mak, E., Carruthers, J., Scott, A., & Calne, D. B. (1985) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s031716710003540x · Cited by 303
Schiavo, G., Poulain, B., Rossetto, O., Benfenati, F., Tauc, L., & Montecucco, C. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05441.x · Cited by 297
Self-citationSynaptotagmins I and II mediate entry of botulinum neurotoxin B into cells
Dong, M., Richards, D. A., Goodnough, M. C., Tepp, W. H., Johnson, E. A., & Chapman, E. R. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305098 · Cited by 296
Botulinum neurotoxins are zinc proteins.
Schiavo, G., Rossetto, O., Santucci, A., DasGupta, B. R., & Montecucco, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35863-0 · Cited by 291
Self-citationCherington, M. (1998) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199806)21:6<701::aid-mus1>3.0.co;2-b · Cited by 279
Facing depression with botulinum toxin: A randomized controlled trial
Wollmer, M. A., de Boer, C., Kalak, N., Beck, J., Götz, T., Schmidt, T., Hodzic, M., Bayer, U., Kollmann, T., Kollewe, K., et al. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.01.027 · Cited by 278
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders
Hallett, M., Albanese, A., Dressler, D., Segal, K. R., Simpson, D. M., Truong, D., & Jankovic, J. (2013) · Toxicon · doi:10.1016/j.toxicon.2012.12.004 · Cited by 272
Hennenlotter, A., Dresel, C., Castrop, F., Ceballos-Baumann, A. O., Wohlschläger, A. M., & Haslinger, B. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn104 · Cited by 269
Quantal acetylcholine release at the vertebrate neuromuscular junction.
Van der Kloot, W., & Molgó, J. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.4.899 · Cited by 269
Attal, N., de Andrade, D. C., Adam, F., Ranoux, D., Teixeira, M. J., Galhardoni, R., Raicher, I., Üçeyler, N., Sommer, C., & Bouhassira, D. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00017-x · Cited by 253
Wienisch, M., & Klingauf, J. (2006) · Nature Neuroscience · doi:10.1038/nn1739 · Cited by 251
Nonlytic viral spread enhanced by autophagy components
Bird, S. W., Maynard, N. D., Covert, M. W., & Kirkegaard, K. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401437111 · Cited by 250
Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity
Jin, R., Rummel, A., Binz, T., & Brunger, A. T. (2006) · Nature · doi:10.1038/nature05387 · Cited by 236
Variability, Heritability and Environmental Determinants of Human Plasma N-Glycome
Gornik, O., Rudan, I., Campbell, H., Hayward, C., Bones, J., Rudd, P. M., Lauc, G., & Wright, A. F. (2008) · Cited by 235
Lew, M. F., Adornato, B. T., Duane, D. D., Dykstra, D. D., Factor, S. A., Massey, J. M., Brin, M. F., Jankovic, J., Rodnitzky, R. L., Singer, C., et al. (1997) · Neurology · doi:10.1212/wnl.49.3.701 · Cited by 233
Duchen, L. W. (1971) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(71)90129-8 · Cited by 231
Glycosylated SV2A and SV2B Mediate the Entry of Botulinum Neurotoxin E into Neurons
Dong, M., Liu, H., Tepp, W. H., Johnson, E. A., Janz, R., & Chapman, E. R. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-07-0765 · Cited by 230
Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia
Gilio, F., Curr�, A., Lorenzano, C., Modugno, N., Manfredi, M., & Berardelli, A. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200007)48:1<20::aid-ana5>3.0.co;2-u · Cited by 228
Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission
Meunier, F. A., Schiavo, G., & Molgó, J. (2002) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(01)00086-9 · Cited by 226
Botulinum Neurotoxin Is Shielded by NTNHA in an Interlocked Complex
Gu, S., Rumpel, S., Zhou, J., Strotmeier, J., Bigalke, H., Perry, K., Shoemaker, C. B., Rummel, A., & Jin, R. (2012) · Science · doi:10.1126/science.1214270 · Cited by 224
Molecular Mechanisms of Presynaptic Membrane Retrieval and Synaptic Vesicle Reformation
Kononenko, N. L., & Haucke, V. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.016 · Cited by 220
Kuriyama, A. (2012) · JAMA · doi:10.1001/jama.2012.505 · Cited by 218
Cell entry strategy of clostridial neurotoxins
Binz, T., & Rummel, A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06093.x · Cited by 207
Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single Ala-Ala peptide bond.
Schiavo, G., Malizio, C., Trimble, W. S., Polverino de Laureto, P., Milan, G., Sugiyama, H., Johnson, E. A., & Montecucco, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31976-2 · Cited by 203
Self-citationVaidyanathan, V. V., Yoshino, K., Jahnz, M., Dörries, C., Bade, S., Nauenburg, S., Niemann, H., & Binz, T. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720327.x · Cited by 201
Botulinum toxins: Mechanisms of action, antinociception and clinical applications
Wheeler, A., & Smith, H. S. (2013) · Toxicology · doi:10.1016/j.tox.2013.02.006 · Cited by 200
Botulinum Neurotoxins A and E Undergo Retrograde Axonal Transport in Primary Motor Neurons
Restani, L., Giribaldi, F., Manich, M., Bercsenyi, K., Menendez, G., Rossetto, O., Caleo, M., & Schiavo, G. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003087 · Cited by 194
Self-citationBotulinum Toxin Dilution and Endplate Targeting in Spasticity: A Double-Blind Controlled Study
Gracies, J.-M., Lugassy, M., Weisz, D. J., Vecchio, M., Flanagan, S., & Simpson, D. M. (2009) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2008.04.030 · Cited by 193
SNARE complexes and neuroexocytosis: how many, how close?
Montecucco, C., Schiavo, G., & Pantano, S. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.05.002 · Cited by 192
Self-citationFinzi, E., & Rosenthal, N. E. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.11.006 · Cited by 187
Priori, A., Berardelli, A., Mercuri, B., & Manfredi, M. (1995) · Brain · doi:10.1093/brain/118.3.801 · Cited by 187
Transport mechanisms in acetylcholine and monoamine storage
Parsons, S. M. (2000) · The FASEB Journal · doi:10.1096/fj.00-0203rev · Cited by 185
Mechanisms of disease: The human N-glycome
Lauc, G., Pezer, M., Rudan, I., & Campbell, H. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.10.016 · Cited by 184
Factors associated with chronic depressive episodes: a preliminary report from the STAR‐D project
Gilmer, W. S., Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Luther, J., Howland, R. H., Yohanna, D., Khan, A., & Alpert, J. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00633.x · Cited by 181
Treatment of Depression with Botulinum Toxin A: A Case Series
FINZI, E., & WASSERMAN, E. (2006) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2006.32136.x · Cited by 181
Immunogenicity of botulinum toxins
Naumann, M., Boo, L. M., Ackerman, A. H., & Gallagher, C. J. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-012-0893-9 · Cited by 179
Rummel, A., Eichner, T., Weil, T., Karnath, T., Gutcaits, A., Mahrhold, S., Sandhoff, K., Proia, R. L., Acharya, K. R., Bigalke, H., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609713104 · Cited by 179
Clinical Uses of Botulinum Neurotoxins: Current Indications, Limitations and Future Developments
Chen, S. (2012) · Toxins · doi:10.3390/toxins4100913 · Cited by 179
Fischer, A., & Montal, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703619200 · Cited by 170
Safety and efficacy of botulinum toxin type A following long‐term use
Naumann, M., Albanese, A., Heinen, F., Molenaers, G., & Relja, M. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01652.x · Cited by 169
Uptake of Botulinum Neurotoxin into Cultured Neurons
Keller, J. E., Cai, F., & Neale, E. A. (2003) · Biochemistry · doi:10.1021/bi0356698 · Cited by 167
Longins and their longin domains: regulated SNAREs and multifunctional SNARE regulators
ROSSI, V, BANFIELD, D., VACCA, M., DIETRICH, L., UNGERMANN, C., DESPOSITO, M., GALLI, T., & FILIPPINI, F. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.10.002 · Cited by 165
Dynamin Inhibition Blocks Botulinum Neurotoxin Type A Endocytosis in Neurons and Delays Botulism
Harper, C. B., Martin, S., Nguyen, T. H., Daniels, S. J., Lavidis, N. A., Popoff, M. R., Hadzic, G., Mariana, A., Chau, N., McCluskey, A., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.283879 · Cited by 163
Rummel, A., Häfner, K., Mahrhold, S., Darashchonak, N., Holt, M., Jahn, R., Beermann, S., Karnath, T., Bigalke, H., & Binz, T. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06298.x · Cited by 162
Boyken, J., Grønborg, M., Riedel, D., Urlaub, H., Jahn, R., & Chua, J. J. E. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.027 · Cited by 161
Evidence for Anterograde Transport and Transcytosis of Botulinum Neurotoxin A (BoNT/A)
Restani, L., Antonucci, F., Gianfranceschi, L., Rossi, C., Rossetto, O., & Caleo, M. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2618-11.2011 · Cited by 160
Self-citationMembrane translocation by anthrax toxin
Collier, R. J. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.06.003 · Cited by 158
A Focused Review on the Use of Botulinum Toxins for Neuropathic Pain
Argoff, C. E. (2002) · The Clinical Journal of Pain · doi:10.1097/00002508-200211001-00010 · Cited by 158
Marinelli, S., Vacca, V., Ricordy, R., Uggenti, C., Tata, A. M., Luvisetto, S., & Pavone, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047977 · Cited by 153
Glycosphingolipid behaviour in complex membranes
Prinetti, A., Loberto, N., Chigorno, V., & Sonnino, S. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.09.001 · Cited by 152
Clostridium botulinum in the post-genomic era
Peck, M. W., Stringer, S. C., & Carter, A. T. (2010) · Food Microbiology · doi:10.1016/j.fm.2010.03.005 · Cited by 151
The blockade of the neurotransmitter release apparatus by botulinum neurotoxins
Pantano, S., & Montecucco, C. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1380-7 · Cited by 150
Self-citationWang, T., Martin, S., Papadopulos, A., Harper, C. B., Mavlyutov, T. A., Niranjan, D., Glass, N. R., Cooper-White, J. J., Sibarita, J., Choquet, D., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3757-14.2015 · Cited by 148
Morra, M. E., Elgebaly, A. S., Elmaraezy, A., Khalil, A. M., Altibi, A. M. A., Vu, T. L.-H., Mostafa, M. R., Huy, N. T., & Hirayama, K. (2016) · The Journal of Headache and Pain · doi:10.1186/s10194-016-0651-8 · Cited by 143
Double Receptor Anchorage of Botulinum Neurotoxins Accounts for their Exquisite Neurospecificity
Rummel, A. (2012) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-33570-9_4 · Cited by 142
Magid, M., Reichenberg, J. S., Poth, P. E., Robertson, H. T., LaViolette, A. K., Krüger, T. H. C., & Wollmer, M. A. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08845 · Cited by 142
Esquenazi, A., Albanese, A., Chancellor, M. B., Elovic, E. P., Segal, K. R., Simpson, D. M., Smith, C. P., & Ward, A. B. (2012) · Toxicon · doi:10.1016/j.toxicon.2012.11.025 · Cited by 140
Botulinum Neurotoxin D Uses Synaptic Vesicle Protein SV2 and Gangliosides as Receptors
Peng, L., Tepp, W. H., Johnson, E. A., & Dong, M. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002008 · Cited by 132
Johnson, E. A., & Montecucco, C. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01511-4 · Cited by 130
Self-citationCARRUTHERS, J. D. A., Burgess, C., Day, D., Fabi, S. G., Goldie, K., Kerscher, M. J., Nikolis, A., Pavicic, T., Rho, N., Rzany, B., et al. (2016) · Dermatologic Surgery · doi:10.1097/dss.0000000000000754 · Cited by 130
Plasma membrane localization signals in the light chain of botulinum neurotoxin
Fernández‐Salas, E., Steward, L. E., Ho, H., Garay, P. E., Sun, S. W., Gilmore, M. A., Ordas, J. V., Wang, J., Francis, J., & Aoki, K. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400229101 · Cited by 129
Binding of Clostridium botulinum Type C and D Neurotoxins to Ganglioside and Phospholipid
Tsukamoto, K., Kohda, T., Mukamoto, M., Takeuchi, K., Ihara, H., Saito, M., & Kozaki, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507596200 · Cited by 129
Structure of a Bimodular Botulinum Neurotoxin Complex Provides Insights into Its Oral Toxicity
Lee, K., Gu, S., Jin, L., Le, T. T. N., Cheng, L. W., Strotmeier, J., Kruel, A. M., Yao, G., Perry, K., Rummel, A., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003690 · Cited by 128
Meng, J., Wang, J., Steinhoff, M. S., & Dolly, J. O. (2016) · Scientific Reports · doi:10.1038/srep21226 · Cited by 127
Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A
Benoit, R., FREY, D. J., Hilbert, M., Kevenaar, J. T., Wieser, M. M., Stirnimann, C. U., McMillan, D., Ceska, T., Lebon, F., Jaussi, R., et al. (2013) · Nature · doi:10.1038/nature12732 · Cited by 124
Drug Insight: biological effects of botulinum toxin A in the lower urinary tract
Chancellor, M. B., Fowler, C. J., Apostolidis, A., de Groat, W. C., Smith, C. P., Somogyi, G. T., & Aoki, K. R. (2008) · Nature Clinical Practice Urology · doi:10.1038/ncpuro1124 · Cited by 123
Giladi, N. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00151-2 · Cited by 123
Rogozhin, A., Pang, K. K., Bukharaeva, E. A., Young, C., & Slater, C. R. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.153569 · Cited by 123
Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin
Sugawara, Y., Matsumura, T., Takegahara, Y., Jin, Y., Tsukasaki, Y., Takeichi, M., & Fujinaga, Y. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.200910119 · Cited by 123
N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A
Yao, G., Zhang, S., Mahrhold, S., Lam, K. H., Stern, D., Bagramyan, K. A., Perry, K., Kalkum, M., Rummel, A., Dong, M., et al. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3245 · Cited by 118
Pellizzari, R., Rossetto, O., Lozzi, L., Giovedı̀, S., Johnson, E. A., Shone, C. C., & Montecucco, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20353 · Cited by 116
Self-citationGangliosides are the binding substances in neural cells for tetanus and botulinum toxins in mice
Kitamura, M. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00140-7 · Cited by 115
The Role of the Synaptic Protein SNAP-25 in the Potency of Botulinum Neurotoxin Type A
Keller, J. E., & Neale, E. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010992200 · Cited by 114
Whitemarsh, R. C. M., Tepp, W. H., Bradshaw, M., Lin, G., Pier, C. L., Scherf, J. M., Johnson, E. A., & Pellett, S. (2013) · Infection and Immunity · doi:10.1128/iai.00536-13 · Cited by 113
Vesicular Neurotransmitter Transporter: Bioenergetics and Regulation of Glutamate Transport
Omote, H., Miyaji, T., Juge, N., & Moriyama, Y. (2011) · Biochemistry · doi:10.1021/bi200567k · Cited by 112
Homologues of insulinase, a new superfamily of metalloendopeptidases
Rawlings, N. D., & Barrett, A. J. (1991) · Biochemical Journal · doi:10.1042/bj2750389 · Cited by 110
Interconversion of Type C and D Strains of Clostridium botulinum by Specific Bacteriophages
Eklund, M. W., & Poysky, F. T. (1974) · Applied Microbiology · doi:10.1128/am.27.1.251-258.1974 · Cited by 109
Botulinum Neurotoxin Heavy Chain Belt as an Intramolecular Chaperone for the Light Chain
Brünger, A. T., Breidenbach, M. A., Jin, R., Fischer, A. E., Santos, J. S., & Montal, M. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030113 · Cited by 108
Bullens, R. W. M., O’Hanlon, G. M., Wagner, E., Molenaar, P. C., Furukawa, K., Furukawa, K., Plomp, J. J., & Willison, H. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-16-06876.2002 · Cited by 107
Pirazzini, M., Tehran, D. A., Zanetti, G., Megighian, A., Scorzeto, M., Fillo, S., Shone, C. C., Binz, T., Rossetto, O., Lista, F. R., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.017 · Cited by 107
Self-citationModes and mechanisms of synaptic vesicle recycling
Soykan, T., Maritzen, T., & Haucke, V. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2016.03.005 · Cited by 107
Peng, L., Liu, H., Ruan, H., Tepp, W. H., Stoothoff, W. H., Brown, R. H., Johnson, E. A., Yao, W., Zhang, S., & Dong, M. (2013) · Nature Communications · doi:10.1038/ncomms2462 · Cited by 106
Receptor and substrate interactions of clostridial neurotoxins
Brünger, A. T., & Rummel, A. (2009) · Toxicon · doi:10.1016/j.toxicon.2008.12.027 · Cited by 104
Pirazzini, M., Tehran, D. A., Leka, O., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.08.014 · Cited by 101
Self-citationBotulinum Neurotoxin A Impairs Neurotransmission Following Retrograde Transynaptic Transport
Restani, L., Novelli, E., Bottari, D., Leone, P., Barone, I., Galli‐Resta, L., Strettoi, E., & Caleo, M. (2012) · Traffic · doi:10.1111/j.1600-0854.2012.01369.x · Cited by 100
Bade, S., Rummel, A., Reisinger, C., Karnath, T., Ahnert‐Hilger, G., Bigalke, H., & Binz, T. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02844.x · Cited by 100
Peng, L., Berntsson, R. P. ‐., Tepp, W. H., Pitkin, R. M., Johnson, E. A., Stenmark, P., & Dong, M. (2012) · Journal of Cell Science · doi:10.1242/jcs.103564 · Cited by 100
The long journey of botulinum neurotoxins into the synapse
Rummel, A. (2015) · Toxicon · doi:10.1016/j.toxicon.2015.09.009 · Cited by 99
Targeting botulinum neurotoxin persistence by the ubiquitin-proteasome system
Tsai, Y. C., Maditz, R., Kuo, C.-L., Fishman, P. S., Shoemaker, C. B., Oyler, G. A., & Weissman, A. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008302107 · Cited by 98
Physiological effects of botulinum toxin in spasticity
Graciès, J. (2004) · Movement Disorders · doi:10.1002/mds.20065 · Cited by 97
Botulinum Neurotoxin a Blocks Synaptic Vesicle Exocytosis but Not Endocytosis at the Nerve Terminal
Neale, E. A., Bowers, L. M., Jia, M., Bateman, K. E., & Williamson, L. C. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.6.1249 · Cited by 97
The first non Clostridial botulinum-like toxin cleaves VAMP within the juxtamembrane domain
Zornetta, I., Tehran, D. A., Arrigoni, G., Anniballi, F., Bano, L., Leka, O., Zanotti, G., Binz, T., & Montecucco, C. (2016) · Scientific Reports · doi:10.1038/srep30257 · Cited by 96
Self-citationBeyond muscular effects: depression of spinal recurrent inhibition after botulinum neurotoxin A
Marchand‐Pauvert, V., Aymard, C., Giboin, L., Dominici, F., Rossi, A., & Mazzocchio, R. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.239178 · Cited by 92
Signalling endosomes in axonal transport: Travel updates on the molecular highway
Schmieg, N., Menendez, G., Schiavo, G., & Terenzio, M. (2013) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2013.10.004 · Cited by 92
Current Status and Future Directions of Botulinum Neurotoxins for Targeting Pain Processing
Pellett, S., Yaksh, T. L., & Ramachandran, R. (2015) · Toxins · doi:10.3390/toxins7114519 · Cited by 91
Muraro, L., Tosatto, S. C. E., Motterlini, L., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.037 · Cited by 90
Assembly and Function of the Botulinum Neurotoxin Progenitor Complex
Gu, S., & Jin, R. (2012) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-45790-0_2 · Cited by 89
Criado, M., Gil, A., Viniegra, S., & Gutiérrez, L. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7256 · Cited by 89
The Extracranial Vascular Theory of Migraine—A Great Story Confirmed by the Facts
Shevel, E. (2011) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.01844.x · Cited by 86
Jacky, B., Garay, P. E., Dupuy, J., Nelson, J. B., Cai, B. B., Molina, Y., Wang, J., Steward, L. E., Broide, R. S., Francis, J., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003369 · Cited by 84
Naumann, M. K., Dressler, D. W., Hallett, M., Jankovic, J. J., Schiavo, G., Segal, K. R., & Truong, D. D. (2012) · Toxicon · doi:10.1016/j.toxicon.2012.10.020 · Cited by 84
Huang, X., Wheeler, M. B., Kang, Y., Sheu, L., Lukács, G. L., Trimble, W. S., & Gaisano, H. Y. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.7.0130 · Cited by 83
Persistence of Botulinum Neurotoxin A Subtypes 1-5 in Primary Rat Spinal Cord Cells
Whitemarsh, R. C. M., Tepp, W. H., Johnson, E. A., & Pellett, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090252 · Cited by 83
Albanese, A., & Lalli, S. (2009) · Movement Disorders · doi:10.1002/mds.22597 · Cited by 82
Berliocchi, L., Fava, E., Leist, M., Horvat, V., Dinsdale, D. D., Read, D., & Nicotera, P. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200406126 · Cited by 82
Botulinum Toxin Type A as a Therapeutic Agent against Headache and Related Disorders
Luvisetto, S., Gazerani, P., Cianchetti, C., & Pavone, F. (2015) · Toxins · doi:10.3390/toxins7093818 · Cited by 81
Strotmeier, J., Willjes, G., Binz, T., & Rummel, A. (2012) · FEBS Letters · doi:10.1016/j.febslet.2011.12.037 · Cited by 80
Colasante, C., Rossetto, O., Morbiato, L., Pirazzini, M., Molgó, J., & Montecucco, C. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8423-9 · Cited by 79
Self-citationEngineering botulinum neurotoxin to extend therapeutic intervention
Chen, S., & Barbieri, J. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903111106 · Cited by 79
Kim, M. J., Neta, M., Davis, F. C., Ruberry, E. J., Dinescu, D., Heatherton, T. F., Stotland, M. A., & Whalen, P. J. (2014) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-4-11 · Cited by 78
Żychowska, M., Rojewska, E., Makuch, W., Luvisetto, S., Pavone, F., Marinelli, S., Przewłocka, B., & Mika, J. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.09.019 · Cited by 78
Matak, I., Rossetto, O., & Lacković, Z. (2014) · Pain · doi:10.1016/j.pain.2014.04.027 · Cited by 77
Self-citationInjectable Treatments for the Aging Face
Wise, J. B., & Greco, T. M. (2006) · Facial Plastic Surgery · doi:10.1055/s-2006-947720 · Cited by 76
Structure of dual receptor binding to botulinum neurotoxin B
Berntsson, R. P. ‐., Peng, L., Dong, M., et al. (2013) · Nature Communications · doi:10.1038/ncomms3058 · Cited by 75
Diffusional spread and confinement of newly exocytosed synaptic vesicle proteins
Gimber, N., Tadeus, G., Maritzen, T., Schmoranzer, J., & Haucke, V. (2015) · Nature Communications · doi:10.1038/ncomms9392 · Cited by 74
EFNS guidelines on management of neurological problems in liver transplantation
Guarino, M., Benito‐León, J., Decruyenaere, J. M. A., Schmutzhard, E., Weißenborn, K., & Stracciari, A. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01353.x · Cited by 74
Engineered Botulinum Neurotoxins as New Therapeutics
Masuyer, G., Chaddock, J. A., Foster, K., & Acharya, K. R. (2013) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135935 · Cited by 72
Isolation and Functional Characterization of the Novel Clostridium botulinum Neurotoxin A8 Subtype
Kull, S., Schulz, K. M., Weisemann, J., Kirchner, S., Schreiber, T., Bollenbach, A., Dąbrowski, P. W., Nitsche, A., Kalb, S. R., Dorner, M. B., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116381 · Cited by 72
Serotonin Pathway Polymorphisms and the Treatment of Major Depressive Disorder and Anxiety Disorders
Helton, S. G., & Lohoff, F. W. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.15 · Cited by 71
Binz, T. (2012) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-33570-9_7 · Cited by 69
Neural transmitter release: from quantal secretion to exocytosis and beyond
Katz, B. (1996) · Journal of Neurocytology · doi:10.1007/bf02284834 · Cited by 69
Botulinum toxins in neurological disease
Comella, C., & Pullman, S. L. (2004) · Muscle & Nerve · doi:10.1002/mus.20033 · Cited by 66
Pirazzini, M., Bordin, F., Rossetto, O., Shone, C. C., Binz, T., & Montecucco, C. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.11.007 · Cited by 66
Self-citationStrotmeier, J., Gu, S., Jutzi, S., Mahrhold, S., Zhou, J., Pich, A., Eichner, T., Bigalke, H., Rummel, A., Jin, R., et al. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07682.x · Cited by 65
Receptor Binding Enables Botulinum Neurotoxin B to Sense Low pH for Translocation Channel Assembly
Sun, S., Suresh, S., Liu, H., Tepp, W. H., Johnson, E. A., Edwardson, J. M., & Chapman, E. R. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.06.012 · Cited by 63
Uptake of Botulinum Neurotoxin in the Intestine
Fujinaga, Y., Sugawara, Y., & Matsumura, T. (2012) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-33570-9_3 · Cited by 60
Raciborska, D. A., Trimble, W. S., & Charlton, M. P. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00270.x · Cited by 59
Botulinum toxin treatment of occupational and focal hand dystonia
Karp, B. I. (2004) · Movement Disorders · doi:10.1002/mds.20025 · Cited by 59
Rossetto, O., Scorzeto, M., Megighian, A., & Montecucco, C. (2013) · Toxicon · doi:10.1016/j.toxicon.2012.12.027 · Cited by 59
Self-citationLi, J.-Y., Jahn, R., & Dahlström, A. B. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90528-2 · Cited by 56
Sugar-binding Sites of the HA1 Subcomponent of Clostridium botulinum Type C Progenitor Toxin
Nakamura, T., Tonozuka, T., Ide, A., Yuzawa, T., Oguma, K., & Nishikawa, A. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.12.031 · Cited by 53
Treating Depression with Botulinum Toxin: A Pooled Analysis of Randomized Controlled Trials
Magid, M., Finzi, E., Krüger, T. H. C., Robertson, H., Keeling, B., Jung, S., Reichenberg, J. S., Rosenthal, N. E., & Wollmer, M. (2015) · Pharmacopsychiatry · doi:10.1055/s-0035-1559621 · Cited by 53
Persistence of Botulinum Neurotoxin Inactivation of Nerve Function
Shoemaker, C. B., & Oyler, G. A. (2012) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-33570-9_9 · Cited by 51
Self-assembly of SNARE fusion proteins into star-shaped oligomers
Rickman, C., Hu, K., Carroll, J., & Davletov, B. A. (2005) · Biochemical Journal · doi:10.1042/bj20041818 · Cited by 51
Differential entry of botulinum neurotoxin A into neuronal and intestinal cells
Couesnon, A., Shimizu, T., & Popoff, M. R. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01253.x · Cited by 50
Architecture of the botulinum neurotoxin complex: a molecular machine for protection and delivery
Lam, K. H., & Jin, R. (2015) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2015.03.013 · Cited by 49
Molecular dissection of botulinum neurotoxin reveals interdomain chaperone function
Fischer, A. E., & Montal, M. (2013) · Toxicon · doi:10.1016/j.toxicon.2013.01.007 · Cited by 48
Bacterial protein translocation requires only one copy of the SecY complex in vivo
Park, E., & Rapoport, T. A. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201205140 · Cited by 48
Hsp90 is involved in the entry of clostridial neurotoxins into the cytosol of nerve terminals
Tehran, D. A., Pirazzini, M., Leka, O., Mattarei, A., Lista, F. R., Binz, T., Rossetto, O., & Montecucco, C. (2016) · Cellular Microbiology · doi:10.1111/cmi.12647 · Cited by 48
Self-citationCommon aberrations from the normal human plasma N-glycan profile
Pučić‐Baković, M., Pinto, S., Novokmet, M., Knežević, A., Gornik, O., Polašek, O., Vlahoviček, K., Wang, W., Rudd, P. M., Wright, A. F., et al. (2010) · Glycobiology · doi:10.1093/glycob/cwq052 · Cited by 47
McNutt, P. M., Celver, J. P., Hamilton, T. A., & Mesngon, M. T. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.12.132 · Cited by 46
Cited by
Skeletal muscle: A review of molecular structure and function, in health and disease
Mukund, K., & Subramaniam, S. (2020) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1462 · Cited by 664
Balint, B., Mencacci, N. E., Valente, E. M., Pisani, A., Rothwell, J., Jankovic, J., Vidailhet, M., & Bhatia, K. P. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0023-6 · Cited by 344
Mechanisms of Botulinum Toxin Type A Action on Pain
Matak, I., Bölcskei, K., Bach-Rojecky, L., & Helyes, Z. (2019) · Toxins · doi:10.3390/toxins11080459 · Cited by 267
The Epigenetic Dimension of Protein Structure Is an Intrinsic Weakness of the AlphaFold Program
Azzaz, F., Yahi, N., Chahinian, H., & Fantini, J. (2022) · Biomolecules · doi:10.3390/biom12101527 · Cited by 53
Joensuu, M., Syed, P., Saber, S. H., Lanoue, V., Wallis, T. P., Rae, J., Blum, A., Gormal, R. S., Small, C., Sanders, S., et al. (2023) · The EMBO Journal · doi:10.15252/embj.2022112095 · Cited by 34
Metadata
- Authors
- Pirazzini, M., Rossetto, O., Eleopra, R., & Montecucco, C.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2017-04
- Volume
- 69
- Issue
- 2
- Pages
- 200-235
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2598060151
- Cited by
- 768
- References
- 228
- FWCI
- 38.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.